A significant increase in p53 levels and activity was detected in postmortem CNS tissues of patients with ALS [16], while another study reported substantial upregulation of p53 signaling in both induced pluripotent stem cell-derived motor neurons (iPSMNs) and post-mortem spinal cord in ALS [17]. This evidence concerns the gene TP53 and amyotrophic lateral sclerosis.